Apimeds Pharmaceuticals amends bylaws to allow shareholder action by written consent

Apimeds Pharmaceuticals US, Inc.

Board adopted First Amendment to Bylaws on October 15, 2025, effective immediately.
Amendment permits shareholders to take action by written consent without a meeting.
Change provides shareholders an additional mechanism to act outside of annual or special meetings.
No other changes to the bylaws were made; full amendment filed as Exhibit 3.1.

item 5.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Apimeds Pharmaceuticals US, Inc.: Bylaws amended to allow shareholder action by written consent (effective 2025-10-15).

Change: bylaw amendment
Effective: 2025-10-15

Exact text from the filing

On October 15, 2025, the board of directors of Apimeds Pharmaceuticals US, Inc. (the “Company”) amended the bylaws to allow shareholder action by written consent.

View on SEC.gov

89 governance changes filed in the last 30 days. Browse all governance changes →

Apimeds Pharmaceuticals US, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-099553

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.